Quinlan Paul T. - 22 Jan 2025 Form 4 Insider Report for Oruka Therapeutics, Inc. (ORKA)

Role
General Counsel
Signature
/s/ Paul Quinlan
Issuer symbol
ORKA
Transactions as of
22 Jan 2025
Net transactions value
$0
Form type
4
Filing time
24 Jan 2025, 16:42:51 UTC
Previous filing
06 Sep 2024
Next filing
23 Jan 2026
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ORKA Employee Stock Option (right to buy) Award $0 +162,500 $0.000000 162,500 22 Jan 2025 Common Stock 162,500 $12.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 1/48 of the underlying shares monthly from January 1, 2025.